ICICI Prudential Nifty Pharma Index Fund Regular Growth

Fund Overview

Fund Size

₹163 Cr

Expense Ratio

1.19%

ISIN

INF109KC18L6

Minimum SIP

₹1,000

Exit Load

No Charges

Inception Date

15 Dec 2022

About this fund

ICICI Prudential Nifty Pharma Index Fund Regular Growth is a Index Funds mutual fund schemes offered by ICICI Prudential Mutual Fund. This fund has been in existence for 3 years, 10 months and 1 days, having been launched on 15-Dec-22.
As of 15-Oct-26, it has a Net Asset Value (NAV) of ₹19.51, Assets Under Management (AUM) of 163.10 Crores, and an expense ratio of 1.19%.

ICICI Prudential Nifty Pharma Index Fund Regular Growth has given a CAGR return of 19.22% since inception.
The fund's asset allocation comprises around 99.94% in equities, 0.00% in debts, and 0.06% in cash & cash equivalents.
You can start investing in ICICI Prudential Nifty Pharma Index Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹1000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+16.42%

— (Cat Avg.)

3 Years

+18.55%

— (Cat Avg.)

Since Inception

+19.22%

— (Cat Avg.)

Portfolio Summaryas of 30th September 2026

Equity	₹163 Cr	99.94%
Others	₹0.1 Cr	0.06%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹31.81 Cr	19.50%
Divi's Laboratories Ltd	Equity	₹19.52 Cr	11.97%
Laurus Labs Ltd	Equity	₹12.75 Cr	7.82%
Cipla Ltd	Equity	₹12.52 Cr	7.68%
Dr Reddy's Laboratories Ltd	Equity	₹12.43 Cr	7.62%
Torrent Pharmaceuticals Ltd	Equity	₹11.68 Cr	7.16%
Lupin Ltd	Equity	₹8.15 Cr	5.00%
Aurobindo Pharma Ltd	Equity	₹7.64 Cr	4.68%
Glenmark Pharmaceuticals Ltd	Equity	₹5.81 Cr	3.56%
Alkem Laboratories Ltd	Equity	₹5.15 Cr	3.16%
Zydus Lifesciences Ltd	Equity	₹4.76 Cr	2.92%
Mankind Pharma Ltd	Equity	₹4.69 Cr	2.88%
Ipca Laboratories Ltd	Equity	₹4.43 Cr	2.71%
Biocon Ltd	Equity	₹4.27 Cr	2.62%
Gland Pharma Ltd	Equity	₹3.82 Cr	2.34%
Sai Life Sciences Ltd	Equity	₹3.49 Cr	2.14%
Wockhardt Ltd	Equity	₹2.89 Cr	1.77%
Ajanta Pharma Ltd	Equity	₹2.73 Cr	1.67%
Treps	Cash - Repurchase Agreement	₹2.45 Cr	1.50%
Net Current Assets	Cash	₹-2.35 Cr	1.44%
Abbott India Ltd	Equity	₹2.34 Cr	1.43%
Piramal Pharma Ltd	Equity	₹2.12 Cr	1.30%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹163 Cr	99.94%

Risk & Performance Ratios

Fund Managers

Nishit Patel

Since December 2022

Ashwini Bharucha

Since December 2024

Venus Ahuja

Since November 2025

Additional Scheme Detailsas of 30th September 2026

ISIN

INF109KC18L6

Expense Ratio

1.19%

Exit Load

No Charges

Fund Size

₹163 Cr

Age

3 years 10 months

Lumpsum Minimum

₹1,000

Fund Status

Open Ended Investment Company

Benchmark

Nifty Pharma TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Index Funds Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Axis Nifty EV & New Age Automotive Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Axis Nifty EV & New Age Automotive Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty Midcap 150 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty 100 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Quant Nifty Midcap 150 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Quant Nifty 100 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty 50 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Quant Nifty 50 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Motilal Oswal Nifty Midcap150 Plus 8-13 yr G-Sec 70:30 Index Fund Direct Growth Very High Risk	-	1.0%	-	-
Motilal Oswal Nifty Midcap150 Plus 8-13 yr G-Sec 70:30 Index Fund Regular Growth Very High Risk	-	1.0%	-	-
Kotak Nifty 500 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Kotak Nifty 500 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Aditya Birla Sun Life BSE Total Market ETF Very High Risk	-	-	-	-
HDFC Nifty LargeMidcap250 Plus 8-13 yr G-sec 70 30 Index Fund Regular Growth High Risk	-	0.0%	-	-
HDFC Nifty LargeMidcap250 Plus 8-13 yr G-sec 70 30 Index Fund Direct Growth High Risk	-	0.0%	-	-
Aditya Birla Sun Life BSE Total Market Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Aditya Birla Sun Life BSE Total Market Index Fund Direct Growth Very High Risk	-	0.0%	-	-
HDFC FTSE India Equity ETF Very High Risk	-	-	-	-
Motilal Oswal Nifty REITs & Realty Index Fund Regular Growth Very High Risk	-	1.0%	-	-
Motilal Oswal Nifty REITs & Realty Index Fund Direct Growth Very High Risk	-	1.0%	-	-
Zerodha Nifty Next 100 ETF Very High Risk	-	-	-	-
HDFC BSE REITS and Commercial Real Estate Index Fund Regular Growth Very High Risk	-	0.0%	₹32.03 Cr	-
HDFC BSE REITS and Commercial Real Estate Index Fund Direct Growth Very High Risk	-	0.0%	₹32.03 Cr	-
Kotak Nifty Capital Markets Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Kotak Nifty Capital Markets Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Invesco India Nifty Chemical Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Axis Nifty500 Low Volatility 50 Index Fund Regular Growth Very High Risk	-	0.0%	₹29.13 Cr	-
Axis Nifty500 Low Volatility 50 Index Fund Direct Growth Very High Risk	-	0.0%	₹29.13 Cr	-
Invesco India Nifty Chemical Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Mirae Asset BSE Information Technology Index Fund Direct Growth Very High Risk	-	0.0%	₹10.60 Cr	-
Mirae Asset BSE Information Technology Index Fund Regular Growth Very High Risk	-	0.0%	₹10.60 Cr	-
Navi Nifty REITs & Realty Index Fund Direct Growth Very High Risk	-	0.0%	₹16.02 Cr	-
Navi Nifty REITs & Realty Index Fund Regular Growth Very High Risk	-	0.0%	₹16.02 Cr	-
UTI BSE India Sector Leaders Index Fund Regular Growth Very High Risk	-	0.0%	-	-
UTI BSE India Sector Leaders Index Fund Direct Growth Very High Risk	-	0.0%	-	-
UTI BSE India Sector Leaders Exchange Traded Fund Very High Risk	-	-	₹7.15 Cr	-
JioBlackRock Nifty Next 50 Index Fund Regular Growth Very High Risk	0.8%	0.0%	₹220.42 Cr	-
JioBlackRock Nifty 50 Index Fund Regular Growth Very High Risk	0.5%	0.0%	₹264.38 Cr	-
JioBlackRock Nifty Midcap 150 Index Fund Regular Growth Very High Risk	0.8%	0.0%	₹266.42 Cr	-
JioBlackRock Nifty Smallcap 250 Index Fund Regular Growth Very High Risk	0.8%	0.0%	₹392.92 Cr	-
Mirae Asset BSE LargeMid (60 40) Stable Dividend 50 ETF Very High Risk	0.1%	-	₹22.29 Cr	-
UTI Nifty 500 Index Fund Direct Growth Very High Risk	-	0.0%	₹101.72 Cr	-
UTI Nifty 500 Index Fund Regular Growth Very High Risk	-	0.0%	₹101.72 Cr	-
Axis Nifty Energy Index Fund Regular Growth Very High Risk	1.1%	0.0%	₹89.24 Cr	-
Axis Nifty Energy Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹89.24 Cr	-
JioBlackRock Nifty 50 ETF Very High Risk	0.1%	-	₹76.58 Cr	-
Kotak Nifty Bank Index Fund Regular Growth Very High Risk	0.5%	0.0%	₹6.92 Cr	-
Kotak Nifty Bank Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹6.92 Cr	-
Edelweiss Nifty REITs & Realty Index Fund Regular Growth Very High Risk	1.1%	0.0%	₹167.36 Cr	-
Edelweiss Nifty REITs & Realty Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹167.36 Cr	-

About the AMC

ICICI Prudential Mutual Fund

+91 22 26428000

https://www.icicipruamc.com/

Total AUM

₹12,32,494 Cr

Address

3rd Floor, Hallmark Business Plaza, Mumbai, 400 051

Other Funds by ICICI Prudential Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
ICICI Prudential Contra Fund Regular Growth Very High Risk	-	1.0%	-	-
ICICI Prudential Life Cycle Fund 2036 Direct Growth Very High Risk	-	3.0%	₹29.55 Cr	-
ICICI Prudential Life Cycle Fund 2041 Direct Growth Very High Risk	-	3.0%	₹55.15 Cr	-
ICICI Prudential Life Cycle Fund 2031 Direct Growth Very High Risk	-	3.0%	₹44.40 Cr	-
ICICI Prudential Dynamic Asset Allocation Passive FOF Direct Growth Very High Risk	-	1.0%	₹17.26 Cr	-
ICICI Prudential Multi-Asset Active FOF Direct Growth Very High Risk	0.3%	1.0%	₹2512.53 Cr	-
ICICI Prudential Balanced Hybrid Fund Direct Growth High Risk	2.5%	1.0%	₹219.41 Cr	-
iSIF Active Asset Allocator Long-Short Fund Direct Growth Very High Risk	1.7%	1.0%	₹983.83 Cr	-
iSIF Equity Long-Short Fund Direct Growth Very High Risk	2.7%	1.0%	₹599.34 Cr	-
ICICI Prudential Diversified Equity All Cap Active FOF Direct Growth Very High Risk	1.0%	1.0%	₹945.72 Cr	-
iSIF Equity Ex-Top 100 Long-Short Fund Direct Growth Very High Risk	1.5%	1.0%	₹2475.27 Cr	-
iSIF Hybrid Long-Short Fund Direct Growth Very High Risk	1.1%	1.0%	₹1323.11 Cr	-
ICICI Prudential Conglomerate Fund Direct Growth Moderately High risk	1.4%	1.0%	₹763.49 Cr	-
ICICI Prudential Active Momentum Fund Direct Growth Moderate Risk	1.8%	1.0%	₹2097.15 Cr	3.7%
ICICI Prudential Nifty Private Bank Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹57.46 Cr	-0.1%
ICICI Prudential Nifty Top 15 Equal Weight Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹33.74 Cr	-11.1%
ICICI Prudential Nifty200 Quality 30 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹23.90 Cr	-6.1%
ICICI Prudential Quality Fund Direct Growth Very High Risk	1.3%	1.0%	₹2002.35 Cr	1.8%
ICICI Prudential Nifty EV & New Age Automotive ETF FOF Direct Growth Very High Risk	0.4%	0.0%	₹50.99 Cr	-3.6%
ICICI Prudential CRISIL-IBX Financial Services 3-6 Months Debt Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹538.78 Cr	6.9%
ICICI Prudential CRISIL-IBX AAA Bond Financial Services Index - Dec 2026 Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹8.51 Cr	-
ICICI Prudential Rural Opportunities Fund Direct Growth Moderate Risk	1.2%	1.0%	₹1895.51 Cr	-9.1%
ICICI Prudential Nifty 500 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹102.15 Cr	-4.9%
ICICI Prudential Equity Minimum Variance Fund Direct Growth Very High Risk	1.9%	1.0%	₹2450.58 Cr	-3.7%
ICICI Prudential Nifty200 Value 30 Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹187.92 Cr	4.0%
ICICI Prudential Energy Opportunities Fund Direct Growth Very High Risk	1.1%	1.0%	₹8029.31 Cr	8.5%
ICICI Prudential Fixed Maturity Plan Series 89 91 Days Plan G Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Nifty LargeMidcap 250 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹290.29 Cr	-3.5%
ICICI Prudential Nifty50 Value 20 Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹94.54 Cr	-9.6%
ICICI Prudential Fixed Maturity Plan Series 88 182 Days Plan J Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 125 Days Plan H Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 93 Days Plan P Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1199 Days Plan Q Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1858 Days Plan D Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1226 Days Plan F Direct Growth Low Risk	-	-	₹129.54 Cr	6.1%
ICICI Prudential Long Term Wealth Enhancement Fund Direct Growth Very High Risk	0.8%	0.0%	₹37.52 Cr	-6.7%
ICICI Prudential Fixed Maturity Plan Series 88 1828 Days Plan A Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1833 Days Plan C Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1192 Days Plan R Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 95 Days Plan B Direct Growth Moderately High risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1303 Days Plan S Direct Growth Low Risk	-	0.0%	₹62.28 Cr	5.7%
ICICI Prudential Fixed Maturity Plan Series 88 226 Days Plan E Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Thematic Advantage Fund (FOF) Direct Growth Very High Risk	1.2%	1.0%	₹8894.33 Cr	-1.8%
ICICI Prudential Floating Interest Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹8657.84 Cr	5.9%
ICICI Prudential Gilt Fund Direct Growth Low to Moderate Risk	0.6%	0.0%	₹9117.79 Cr	1.7%
ICICI Prudential All Seasons Bond Fund Direct Growth Moderately High risk	0.6%	0.0%	₹12863.13 Cr	3.6%
ICICI Prudential Long Term Bond Fund Direct Growth Moderate Risk	0.4%	0.0%	₹822.48 Cr	-0.6%
ICICI Prudential Liquid Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹55340.45 Cr	6.5%
ICICI Prudential Innovation Fund Direct Growth Very High Risk	1.2%	1.0%	₹7549.12 Cr	-0.2%
ICICI Prudential Global Stable Equity Fund (FOF) Direct Growth Very High Risk	1.2%	1.0%	₹89.96 Cr	15.0%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of ICICI Prudential Nifty Pharma Index Fund Regular Growth?

The NAV of ICICI Prudential Nifty Pharma Index Fund Regular Growth, as of 15-Oct-2026, is ₹19.51.

What are the returns of ICICI Prudential Nifty Pharma Index Fund Regular Growth?

The fund has generated 16.42% over the last 1 year and 18.55% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of ICICI Prudential Nifty Pharma Index Fund Regular Growth?

The fund's allocation of assets is distributed as 99.94% in equities, 0.00% in bonds, and 0.06% in cash and cash equivalents.

Who manages the ICICI Prudential Nifty Pharma Index Fund Regular Growth?

The fund managers responsible for ICICI Prudential Nifty Pharma Index Fund Regular Growth are:-

Nishit Patel
Ashwini Bharucha
Venus Ahuja

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

ICICI Prudential Nifty Pharma Index Fund Regular Growth

Fund Overview